PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Mayo Clinic: Drug induces morphologic, molecular and clinical remissions in myelofibrosis

2013-12-06
(Press-News.org) Contact information: Joe Dangor
newsbureau@mayo.edu
507-284-5005
Mayo Clinic
Mayo Clinic: Drug induces morphologic, molecular and clinical remissions in myelofibrosis ROCHESTER, Minn. -- Imetelstat, a novel telomerase inhibiting drug, has been found to induce morphologic, molecular and clinical remissions in some patients with myelofibrosis a Mayo Clinic study has found. The results were presented today at the 2013 American Society of Hematology Annual Meeting in New Orleans.

"These are early results but they are promising, says the study's lead author, Ayalew Tefferi, M.D. a hematologist at Mayo Clinic. "Some patients in our clinical trial taking imetelstat obtained dramatic responses and there have been some complete responses which is almost unheard of for drug therapy in this disease."

Myelofibrosis is a chronic myeloid cancer in which bone marrow cells that produce blood cells develop and function abnormally. The result is the formation of scar tissue in the bone marrow (fibrosis), severe anemia that often requires transfusion, weakness, fatigue and an enlarged spleen and liver. Patients with myelofibrosis harbor one of several genetic mutations in their blood stem cells, including JAK2, MPL, CALR, ASXL1 and spliceosome pathway mutations.

"Typically, myelofibrosis is characterized by marrow scarring and although patients may derive symptomatic relief from other treatments such as ruxolitinib, they usually do not revert back to normal bone marrow," Dr. Tefferi says. "Some patients in our trial have reverted back to normal bone marrow."

Imetelstat works by inhibiting telomerase activity in tumor cells which leads to cell death.

Researchers studied imetelstat in 33 patients at Mayo Clinic and have now followed the first 22 patients for a minimum of six months. Among the 22, five patients achieved complete or partial remissions, including reversal of bone marrow fibrosis in four of the five patients. Two of the five patients with complete or partial remission have also experienced complete molecular remissions. The overall response rate was 41 percent.

### MULTIMEDIA ALERT: Video interview is available for journalists on the Mayo Clinic News Network.

Joe Dangor
507-284-5005 (days)
507-284-2511 (evenings)
Email: newsbureau@mayo.edu

Co-authors include Kebede Begna, M.D., Rebecca Laborde, Ph.D., Mrinal Patnaik, M.B.B.S., Curtis Hanson, M.D., Animesh Pardanani, M.B.B.S., Ph.D., Terra Lasho, Darci Zblewski, Christy Finke, Lauren Schimek, and Betsy LaPlant, all of Mayo Clinic and Monic Stuart, M.D., M.P.H. of Geron Corporation.

Financial support for the study was provided by Geron Corporation.

About Mayo Clinic Cancer Center As a leading institution funded by the National Cancer Institute, Mayo Clinic Cancer Center conducts basic, clinical and population science research, translating discoveries into improved methods for prevention, diagnosis, prognosis and therapy. For information on cancer clinical trials, call 507-538-7623.

About Mayo Clinic Mayo Clinic is a nonprofit worldwide leader in medical care, research and education for people from all walks of life. For more information, visit http://www.mayoclinic.org/about and http://www.mayoclinic.org/news.

Journalists can become a member of the Mayo Clinic News Network for the latest health, science and research news and access to video, audio, text and graphic elements that can be downloaded or embedded.


ELSE PRESS RELEASES FROM THIS DATE:

NASA Goddard planetary instruments score a hat trick

2013-12-06
NASA Goddard planetary instruments score a hat trick Planetary instruments from NASA's Goddard Space Flight Center in Greenbelt, Md., hit the trifecta on Dec. 4, running three experiments of the same kind at different places in space. The ...

Study shows how water dissolves stone, molecule by molecule

2013-12-06
Study shows how water dissolves stone, molecule by molecule International team uses computers, experiments to better predict chemical dissolution HOUSTON -- (Dec. 5, 2013) -- Scientists from Rice University and the University of Bremen's Center for Marine Environmental Sciences ...

The gene sequencing that everyone can afford in future

2013-12-06
The gene sequencing that everyone can afford in future DNA sequencing seems to be an eternal theme for human due to the desire of ascertaining the nature of life. Professor QIAN Linmao and his group from Tribology Research Institute, Southwest Jiaotong University were ...

Cigarette smoking after cancer diagnosis increases risk of death

2013-12-06
Cigarette smoking after cancer diagnosis increases risk of death Study shows it is not too late to stop smoking after cancer diagnosis PHILADELPHIA — Men who continued to smoke after a cancer diagnosis had an increased risk of death compared with ...

Stomach 'clock' tells us how much to eat

2013-12-05
Stomach 'clock' tells us how much to eat University of Adelaide researchers have discovered the first evidence that the nerves in the stomach act as a circadian clock, limiting food intake to specific times of the day. The discovery, published ...

CERN, eat your heart out? U of A research team helps identify an interstellar particle accelerator

2013-12-05
CERN, eat your heart out? U of A research team helps identify an interstellar particle accelerator Newly released research in Nature Communications from the University of Alberta has identified the existence of a giant cosmic accelerator above the Earth. By ...

Heads or tails? Random fluctuations in brain cell activity may determine toss-up decisions

2013-12-05
Heads or tails? Random fluctuations in brain cell activity may determine toss-up decisions Life presents us with choices all the time: salad or pizza for lunch? Tea or coffee afterward? How we make these everyday decisions has been a topic of great ...

An ecosystem-based approach to protect the deep sea from mining

2013-12-05
An ecosystem-based approach to protect the deep sea from mining Five hundred miles southeast of Hawai'i, in international waters far out of sight of any land, there are vast mineral resources 5,000 meters below the sea. Manganese nodules, rich in commercially ...

New insights into how human skin attracts mosquitoes could lead to better repellants and traps

2013-12-05
New insights into how human skin attracts mosquitoes could lead to better repellants and traps Every time a mosquito is lured to the scent of your skin, you're at risk of contracting malaria, dengue fever, West Nile virus, or another deadly disease. A study published by ...

Gut bacteria linked to autism-related behavior in mice

2013-12-05
Gut bacteria linked to autism-related behavior in mice Mice whose mothers suffered from infection or inflammation during pregnancy are at greater risk for developing behaviors similar to those seen in people with autism spectrum disorders (ASD). Now, researchers reporting in ...

LAST 30 PRESS RELEASES:

Fig trees convert atmospheric CO2 to stone

Intra-arterial tenecteplase for acute stroke after successful endovascular therapy

Study reveals beneficial microbes that can sustain yields in unfertilized fields

Robotic probe quickly measures key properties of new materials

Climate change cuts milk production, even when farmers cool their cows

Frozen, but not sealed: Arctic Ocean remained open to life during ice ages

Some like it cold: Cryorhodopsins

Demystifying gut bacteria with AI

Human wellbeing on a finite planet towards 2100: new study shows humanity at a crossroads

Unlocking the hidden biodiversity of Europe’s villages

Planned hydrogen refuelling stations may lead to millions of euros in yearly losses

Planned C-sections increase the risk of certain childhood cancers

Adults who have survived childhood cancer are at increased risk of severe COVID-19

Drones reveal extreme coral mortality after bleaching

New genetic finding uncovers hidden cause of arsenic resistance in acute promyelocytic leukemia

Native habitats hold the key to the much-loved smashed avocado’s future

Using lightning to make ammonia out of thin air

Machine learning potential-driven insights into pH-dependent CO₂ reduction

Physician associates provide safe care for diagnosed patients when directly supervised by a doctor

How game-play with robots can bring out their human side

Asthma: patient expectations influence the course of the disease

UNM physician tests drug that causes nerve tissue to emit light, enabling faster, safer surgery

New study identifies EMP1 as a key driver of pancreatic cancer progression and poor prognosis

XPR1 identified as a key regulator of ovarian cancer growth through autophagy and immune evasion

Flexible, eco-friendly electronic plastic for wearable tech, sensors

Can the Large Hadron Collider snap string theory?

Stuckeman professor’s new book explores ‘socially sustainable’ architecture

Synthetic DNA nanoparticles for gene therapy

New model to find treatments for an aggressive blood cancer

Special issue of Journal of Intensive Medicine analyzes non-invasive respiratory support

[Press-News.org] Mayo Clinic: Drug induces morphologic, molecular and clinical remissions in myelofibrosis